Green Thumb Industries Inc. (GTBIF)
(Delayed Data from OTC)
$10.42 USD
+0.07 (0.63%)
Updated Oct 14, 2024 03:59 PM ET
3-Hold of 5 3
A Value C Growth F Momentum C VGM
Price, Consensus and EPS Surprise
GTBIF 10.42 +0.07(0.63%)
Will GTBIF be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for GTBIF based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for GTBIF
BellRing Brands Inc. (BRBR) Hit a 52 Week High, Can the Run Continue?
Green Thumb Industries Inc. (GTBIF) Upgraded to Buy: Here's What You Should Know
GTBIF: What are Zacks experts saying now?
Zacks Private Portfolio Services
Green Thumb Industries Inc. (GTBIF) Q2 Earnings and Revenues Surpass Estimates
Analysts Estimate Verano Holdings Corp. (VRNOF) to Report a Decline in Earnings: What to Look Out for
Green Thumb Industries Inc. (GTBIF) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Other News for GTBIF
Almost Every Major Cannabis Company Could See Positive Cash Flow If 280E Is Removed In 2025
Is Colorado's Cannabis Market Back On Track? A 5% Sales Boost Says Yes
EXCLUSIVE: Medical Marijuana Programs Often Suffer When Recreational Use Is Approved: Expert Proposes Across-The-Board Access For Both (UPDATED)
Rising High: Exclusive talk with cannabis REIT NewLake Capital
EXCLUSIVE: 'I Graduated Cum Laude Because I Used Weed,' Says Cannabis Expert Urging Protection Of Medical Marijuana Programs